Media Summary: Jorge Cortes, MD, The University of Alabama at Birmingham, Birmingham, AL, discusses a recent Delphi Anna Sureda, MD, PhD, Catalan Institute of Oncology, Duran I Reynals Hospital, Barcelona, Spain, provides insight into the EBMT ... Watch the full course and our most up-to-date content here: Create a free account to track ...

Consensus Recommendations For Relapsed Refractory - Detailed Analysis & Overview

Jorge Cortes, MD, The University of Alabama at Birmingham, Birmingham, AL, discusses a recent Delphi Anna Sureda, MD, PhD, Catalan Institute of Oncology, Duran I Reynals Hospital, Barcelona, Spain, provides insight into the EBMT ... Watch the full course and our most up-to-date content here: Create a free account to track ... In this episode of the Oncology Brothers podcast, we dived deep into the complexities of late In a recent interactive webinar, renowned experts Prof. Aurore Perrot, Prof. Hermann Einsele, Assoc. Prof. Karthik Ramasamy and ... Featuring perspectives from Dr Melissa Alsina, Dr Hans Lee, Dr Sagar Lonial and Dr Paul G Richardson, moderated by Dr Lonial, ...

In this episode of the Oncology Brothers podcast we continued our treatment algorithm series, focusing on early ... Hear an expert's take on nuances of managing Philippe Moreau, MD, Nantes University Hospital, Nantes, France, talks on optimizing the treatment sequence for patients with ...

Photo Gallery

Consensus recommendations for relapsed/refractory IDH1-mutated AML treatment
Relapsed/Refractory Follicular Lymphoma — Selection and Sequencing of Other Novel Therapies
Insights into the EBMT Consensus on transplantation in Hodgkin lymphoma
Defining Relapsed and Refractory Myeloma; what's the difference?
Optimizing the Current and Future Management of Relapsed/Refractory Diffuse
Treatment Algorithm of Late Relapsed/Refractory Multiple Myeloma (RRMM)
Highlights- Optimising the management of multiple myeloma in the early relapsed refractory setting
Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held in Conjunction with the 20...
Treatment Algorithm of Early Relapsed/Refractory Multiple Myeloma (RRMM)
Ask the Expert: Beyond the Basics in Management of Relapsed/Refractory Multiple Myeloma
Optimal treatment sequencing for relapsed/refractory myeloma
What is relapsed and refractory myeloma? | Experts Explain #myeloma
View Detailed Profile
Consensus recommendations for relapsed/refractory IDH1-mutated AML treatment

Consensus recommendations for relapsed/refractory IDH1-mutated AML treatment

Jorge Cortes, MD, The University of Alabama at Birmingham, Birmingham, AL, discusses a recent Delphi

Relapsed/Refractory Follicular Lymphoma — Selection and Sequencing of Other Novel Therapies

Relapsed/Refractory Follicular Lymphoma — Selection and Sequencing of Other Novel Therapies

Striving for

Insights into the EBMT Consensus on transplantation in Hodgkin lymphoma

Insights into the EBMT Consensus on transplantation in Hodgkin lymphoma

Anna Sureda, MD, PhD, Catalan Institute of Oncology, Duran I Reynals Hospital, Barcelona, Spain, provides insight into the EBMT ...

Defining Relapsed and Refractory Myeloma; what's the difference?

Defining Relapsed and Refractory Myeloma; what's the difference?

Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity Create a free account to track ...

Optimizing the Current and Future Management of Relapsed/Refractory Diffuse

Optimizing the Current and Future Management of Relapsed/Refractory Diffuse

Striving for

Treatment Algorithm of Late Relapsed/Refractory Multiple Myeloma (RRMM)

Treatment Algorithm of Late Relapsed/Refractory Multiple Myeloma (RRMM)

In this episode of the Oncology Brothers podcast, we dived deep into the complexities of late

Highlights- Optimising the management of multiple myeloma in the early relapsed refractory setting

Highlights- Optimising the management of multiple myeloma in the early relapsed refractory setting

In a recent interactive webinar, renowned experts Prof. Aurore Perrot, Prof. Hermann Einsele, Assoc. Prof. Karthik Ramasamy and ...

Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held in Conjunction with the 20...

Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held in Conjunction with the 20...

Featuring perspectives from Dr Melissa Alsina, Dr Hans Lee, Dr Sagar Lonial and Dr Paul G Richardson, moderated by Dr Lonial, ...

Treatment Algorithm of Early Relapsed/Refractory Multiple Myeloma (RRMM)

Treatment Algorithm of Early Relapsed/Refractory Multiple Myeloma (RRMM)

In this episode of the Oncology Brothers podcast we continued our treatment algorithm series, focusing on early ...

Ask the Expert: Beyond the Basics in Management of Relapsed/Refractory Multiple Myeloma

Ask the Expert: Beyond the Basics in Management of Relapsed/Refractory Multiple Myeloma

Hear an expert's take on nuances of managing

Optimal treatment sequencing for relapsed/refractory myeloma

Optimal treatment sequencing for relapsed/refractory myeloma

Philippe Moreau, MD, Nantes University Hospital, Nantes, France, talks on optimizing the treatment sequence for patients with ...

What is relapsed and refractory myeloma? | Experts Explain #myeloma

What is relapsed and refractory myeloma? | Experts Explain #myeloma

Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity Create a free account to track ...

NCCN Guidelines for Relapsed/Refractory MCL

NCCN Guidelines for Relapsed/Refractory MCL

NCCN Guideline